Dr Reddy's acquires a portfolio of 42 ANDAs in US

Drug major Dr Reddy's Laboratories Saturday said it has acquired a portfolio of 42 abbreviated new drug applications (ANDAs) in the US.

The company said it has entered into a definitive agreement to acquire yet to be marketed portfolio of ANDAs, including more than 30 generic injectable products, Dr Reddy's Laboratories said in a regulatory filing.